In Vitro-In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs

被引:31
作者
Kunze, Annett [1 ,2 ]
Huwyler, Joerg [2 ]
Poller, Birk [1 ]
Gutmann, Heike [1 ]
Camenisch, Gian [1 ]
机构
[1] Novartis Inst BioMed Res, Drug Drug Interact Sect, Div Drug Metab & Pharmacokinet, CH-4056 Basel, Switzerland
[2] Univ Basel, Div Pharmaceut Technol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
关键词
in vitro-in vivo correlations (IVIVC); renal clearance; renal reabsorption; permeability; drug transport; in vitro models; membrane transport; pharmacokinetics; LLC-PK1 cell line; clearance prediction; TRANSCELLULAR TRANSPORT; MEMBRANE TRANSPORTERS; LLC-PK1; KIDNEY; PARAMETERS; METABOLISM; MECHANISMS; MONOLAYERS; EXPRESSION; MODEL;
D O I
10.1002/jps.23851
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Renal clearance is a key determinant of the elimination of drugs. To date, only few in vitro-in vivo extrapolation (IVIVE) approaches have been described to predict the renal organ clearance as the net result of glomerular filtration, tubular secretion, and tubular reabsorption. In this study, we measured in LLC-PK1 cells the transport of 20 compounds that cover all four classes of the Biopharmaceutical Drug Disposition System. These data were incorporated into a novel kidney model to predict all renal clearance processes in human. We showed that filtration and secretion were main contributors to the renal organ clearance for all compounds, whereas reabsorption was predominant for compounds assigned to classes 1 and 2. Our results suggest that anionic drugs were not significantly secreted in LLC-PK1 cells, resulting in under-predicted clearances. When all study compounds were included a high overall correlation between the reported and predicted renal organ clearances was obtained (R-2 = 0.83). The prediction accuracy in terms of percentage within twofold and threefold error was 70% and 95%, respectively. In conclusion, our novel IVIVE method allowed to predict the human renal organ clearance and the contribution of each underlying process. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 50 条
  • [41] Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance
    Williamson, Beth
    Harlfinger, Stephanie
    McGinnity, Dermot F.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (11) : 1137 - 1146
  • [42] Developing an In Vitro to In Vivo Extrapolation (IVIVE) Model to Predict Human Milk-to-Plasma Drug Concentration Ratios
    Yang, Hong
    Xue, Ivy
    Gu, Qimei
    Zou, Peng
    Zhang, Tao
    Lu, Yanhui
    Fisher, Jeffery
    Tran, Doanh
    MOLECULAR PHARMACEUTICS, 2022, : 2506 - 2517
  • [43] Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro-In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound
    T'jollyn, Huybrecht
    Snoeys, Jan
    Van Bocxlaer, Jan
    De Bock, Lies
    Annaert, Pieter
    Van Peer, Achiel
    Allegaert, Karel
    Mannens, Geert
    Vermeulen, An
    Boussery, Koen
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (03) : 537 - 543
  • [44] Sublingual permeability of model drugs in New Zealand White Rabbits: In Vitro-In vivo correlation
    Kaur, Navdeep
    Sharma, Pramila
    Li, Xiaoling
    Jasti, Bhaskara
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 668
  • [45] Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro-In Vivo Comparisons
    Wilkinson, David J.
    Southall, Rosalind L.
    Li, Mingguang
    Wright, Lisa M.
    Corfield, Lindsay J.
    Heeley, Thomas A.
    Bratby, Benjamin
    Mannu, Ranbir
    Johnson, Sarah L.
    Shaw, Victoria
    Friett, Holly L.
    Blakeburn, Louise A.
    Kendrick, John S.
    Otteneder, Michael B.
    AAPS JOURNAL, 2017, 19 (04): : 1163 - 1174
  • [46] Comparison of in vitro-in vivo extrapolation of biliary clearance using an empirical scaling factor versus transport-based scaling factors in sandwich-cultured rat hepatocytes
    Zou, Peng
    Liu, Xingrong
    Wong, Susan
    Feng, Meihua Rose
    Liederer, Bianca M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (08) : 2837 - 2850
  • [47] Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail
    Nguyen, James T.
    Tian, Dan-Dan
    Tanna, Rakshit S.
    Hadi, Deena L.
    Bansal, Sumit
    Calamia, Justina C.
    Arian, Christopher M.
    Shireman, Laura M.
    Molnar, Balint
    Horvath, Miklos
    Kellogg, Joshua J.
    Layton, Matthew E.
    White, John R.
    Cech, Nadja B.
    Boyce, Richard D.
    Unadkat, Jashvant D.
    Thummel, Kenneth E.
    Paine, Mary F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (05) : 1342 - 1352
  • [48] In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
    Miners, JO
    Knights, KM
    Houston, JB
    Mackenzie, PI
    BIOCHEMICAL PHARMACOLOGY, 2006, 71 (11) : 1531 - 1539
  • [49] In Vitro-in Vivo Correlation of the Effect of Supersaturation on the Intestinal Absorption of BCS Class 2 Drugs
    Higashino, Haruki
    Hasegawa, Tsubasa
    Yamamoto, Mari
    Matsui, Rie
    Masaoka, Yoshie
    Kataoka, Makoto
    Sakuma, Shinji
    Yamashita, Shinji
    MOLECULAR PHARMACEUTICS, 2014, 11 (03) : 746 - 754
  • [50] Efavirenz in an obese HIV-infected patient - a report and an in vitro-in vivo extrapolation model indicate risk of underdosing
    de Roche, Mirjam
    Siccardi, Marco
    Stoeckle, Marcel
    Livio, Francoise
    Back, David
    Battegay, Manuel
    Marzolini, Catia
    ANTIVIRAL THERAPY, 2012, 17 (07) : 1381 - 1384